Unexplained weight loss (UWL), defined as a loss of 5% or more of total body weight within a six to twelve month period without an identified cause, is a perplexing clinical scenario that often challenges physicians due to its broad differential diagnosis. This article aims to provide a comprehensive approach to evaluating UWL in clinical practice.
Initial evaluation should include a detailed history and physical examination. Key elements to explore include dietary habits, changes in taste or smell, gastrointestinal symptoms, medication use, and psychosocial factors. Physical examination should focus on signs of malnutrition, malignancy, endocrine disorders, or chronic infections.
Laboratory tests should be tailored to each patient’s individual presentation but may include a complete blood count, comprehensive metabolic panel, thyroid function tests, HIV testing, and tumor markers. Imaging studies, such as computed tomography (CT) or positron emission tomography (PET), may be used to identify occult malignancies or systemic diseases.
If initial investigations are unrevealing, specialized testing may be warranted. This can include endoscopic procedures, biopsies, or more advanced imaging studies. In some cases, a watch-and-wait approach may be appropriate, with repeat evaluations over time to see if a diagnosis becomes apparent.
Management of UWL should be guided by the underlying cause, if identified. In cases where no cause is found, symptomatic management, nutritional support, and regular follow-up are key. It is also important to involve a multidisciplinary team, including dietitians and mental health professionals, as appropriate.
UWL is a complex clinical issue that requires a thorough and systematic approach. A detailed history, physical examination, and tailored investigations are crucial in the evaluation process. While the cause of UWL may remain elusive, comprehensive management can help mitigate symptoms and improve patient outcomes.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation